Which Standards Apply to Adult Pull-On Diapers in Canadian Clinics?

Disposable underpads laid out in six sizes above a hospital-style bed made up with a pad

A buyer who asks which standard sits behind a pull-on diaper usually gets an answer that is either five years old or one edition behind. The stack moved twice recently: the vocabulary standards that defined the words were withdrawn in June 2021, and the evaluation guideline was replaced in February 2026. The first useful answer is therefore not a number but an edition and a date.

The product the question is about is a case of 120 adult pull-on diapers, packed as six inner packs of twenty, with a lighter-core Day Comfort 3,000 ml brief in the same range for daytime care plans.

The bed itself is covered separately from the brief. The heavy-absorbency underpads, 30 × 36 in carry their own specification and their own absorbency figure, and a buyer comparing briefs usually ends up specifying both lines.

Disposable underpads laid out in six sizes above a hospital-style bed made up with a pad

What follows separates the federal layer that applies in every province from the two provincial layers that change what a clinic or a licensed home can keep on the shelf. It also sets out the one comparison a buyer holding both a Canadian and an American file has to keep straight.

Illustration of a single adult pull-on brief with a waistband, no tabs and leg cuffs

Which standards apply to an adult pull-on diaper in a Canadian clinic?

Fewer than supplier brochures imply, and two of the frequently cited editions no longer exist.

Standard What it covers Status, checked 10 November 2026
ISO 15621:2026 General guidelines on evaluating absorbent incontinence products for urine, faeces, or both Current. Fourth edition, published 19 February 2026
ISO 15621:2017 The previous edition of the same guidelines Withdrawn 19 February 2026
ISO 11948-1:1996 Whole-product test method for the absorption capacity of the absorbent core Current, last confirmed 7 June 2023
ISO 11948-2:1998 Short-time liquid release (leakage) under light incontinence and low pressure Withdrawn, 2003
ISO 9949-1:1993 and 9949-2:1993 Vocabulary for incontinence conditions and for product terms Both withdrawn 2 June 2021
ISO 17190-1, -5, -9:2020 Tests run on the polyacrylate superabsorbent powder itself Current
ISO 10993-1:2025 and 10993-23:2021 Biological evaluation, including skin irritation testing Current
ISO 15223-1:2021 Symbols used on the pack and in the instructions for use Current

Three readings follow from that table, and each one is a question you can put to a supplier in a single sentence. A specification sheet that still names ISO 15621:2017 was written against an edition withdrawn in February 2026. A sheet that names ISO 11948-2 as its leakage test cites a document withdrawn in 2003, so whatever test produced the number is not that one. A sheet that uses ISO 9949 terms as if they were still current vocabulary is using definitions that were retired in June 2021.

The evaluation guideline that replaced the 2017 edition is also a different kind of document. The ISO 15621 record describes general guidelines on evaluation; it does not set a single pass mark that turns an absorbency figure into a regulatory claim. It tells a buyer what to evaluate and in what order, which is why the sensible request is the test report, not the headline number.

Do the same standards apply in Canada and the United States?

No, and the difference is structural rather than a matter of degree. Canada classifies by risk through the classification rules in the Medical Devices Regulations, while the United States classifies by device type in Title 21.

A non-invasive absorbent product that contacts intact skin falls to Rule 7(1) of Schedule 1, which places all other non-invasive devices in Class I. The same product used on damaged skin does not fall out of that class, because Rule 4(2) places a device intended as a mechanical barrier, for compression or for absorption of exudations in Class I as well. That is worth knowing in a home with a high rate of incontinence-associated dermatitis: the classification does not change with the skin condition.

The American counterpart is 21 CFR 876.5920, which identifies the device as one that "consists of absorbent padding and a fluid barrier and that is intended to protect an incontinent patient's garment from the patient's excreta", classifies it as Class I (general controls), and exempts it from premarket notification subject to the limitations in 876.9. The same paragraph also exempts it from the quality management system requirements of part 820, except the records and complaint file requirements of 820.35 — an exemption last touched by the Federal Register amendment at 90 FR 55985 on 4 December 2025.

Item Canada United States
Classification route Risk-based rules in Schedule 1 of the Medical Devices Regulations Device-type regulation in Title 21
Premarket review No device licence for Class I; section 26 applies a licence to Class II, III and IV only Exempt from 510(k) under 876.5920, subject to 876.9
Who holds the licence The importer or seller holds an establishment licence under section 44(1) The establishment registers and lists; a foreign manufacturer needs a US agent
Labelling language English or French at minimum under section 23(1); both languages where the device is sold to the general public English, unless a foreign-language representation appears, in which case all required statements must also appear in that language
Absorbency figure Core capacity measured to ISO 11948-1 No federal absorbency standard; the figure comes from the manufacturer's method

How do the labelling rules differ between Canada and the United States?

The federal Canadian rule is short and the Quebec overlay is the part buyers miss.

Section 21(1) requires the label to carry, among other items, the expiry date "if the device has one", the directions for use unless they are not required for safe and effective use, and any special storage conditions. The expiry date is to be determined on the basis of the component with "the shortest projected useful life", which for a case of briefs is usually the adhesive or the packaging rather than the core.

Section 23 then sets the language: the information required by section 21(1) must be, as a minimum, in either English or French, and where a device is sold to the general public the specified items must be in both languages. A clinic buying through a professional channel is therefore not in the same position as a pharmacy selling over the counter, and a supplier that prints one language should be able to say which channel the pack was labelled for.

In the United States the labelling regulation at 21 CFR 801.15 works the other way round: it does not require a second language, but if the label carries any representation in a foreign language, every required word and statement must also appear in that language. A pack that adds French for the Canadian market therefore creates an obligation in the United States rather than in Canada.

Quebec adds the strictest rule in the set. Section 51 of the Charter of the French language provides that every inscription on a product, on its container or wrapping, or on a document or object supplied with it — including the directions for use and the warranty certificates — must be drafted in French, that a translation may accompany it, and that no inscription in another language may be given greater prominence or be available on more favourable terms. Section 51.1 carves out a registered trademark with no French version in the register. A supplier shipping an English-only pack into Quebec has a problem at the pack, not at the clinic.

Which Ontario rule decides what a licensed home keeps on the shelf?

Ontario replaced its long-term care statute in 2022, and the instrument that governs today is the Fixing Long-Term Care Act, 2021 with O. Reg. 246/22. The earlier Long-Term Care Homes Act, 2007 and its O. Reg. 79/10 were repealed on 11 April 2022, so a policy manual still citing section numbers from 79/10 is citing a repealed instrument.

Two sections in the current regulation matter to a diapers order. Section 48 requires the licensee to ensure that supplies, equipment and devices are readily available at the home to meet residents' nursing and personal care needs — a stocking duty, not a purchasing preference. Section 56(1) sets what the continence care programme must provide, and its fifth item is the one to read aloud in a vendor meeting: an annual evaluation of residents' satisfaction with the range of continence care products, in consultation with residents, substitute decision-makers and direct care staff, with the evaluation taken into account when purchasing decisions are made, including when vendor contracts are negotiated or renegotiated.

Subsection 56(2)(e) closes the other direction: continence care products are not to be used as an alternative to providing assistance to a person to toilet. A buyer who reads those two provisions together gets the shape of a compliant product decision — the range has to be evaluated with the people who wear and change the product, and the product cannot be doing work that staffing should do. The same regulation's penalty table lists section 56 against a monetary penalty, and section 48 sits in the same table.

For the handling side, section 25(2)(h) of the Occupational Health and Safety Act requires an employer to take every precaution reasonable in the circumstances for the protection of a worker, and Public Health Ontario's routine practices guidance sets the handling frame for soiled products. A community clinic is not licensed under the long-term care statute, but the practice those sections describe is the practice an inspector will compare against.

Which Quebec rule changes what a clinic can hand over?

Quebec splits the purchase from the supply route. A centre local de services communautaires delivers first-line health and social services for its territory, and home support runs through that network rather than through the clinic's own shelf. The practical consequence for stock planning is that a clinic counts only the clients it changes in the room; a client followed at home receives product through the home-support path.

Alongside that sits the labelling duty described above. A Quebec buyer comparing two otherwise identical cases should ask for the pack artwork in French with the directions for use included, because section 51 covers the document supplied with the product and not only the printed bag.

Layer Instrument What it requires Who it binds
Federal Medical Devices Regulations, sections 21 and 23 Label contents, expiry basis, directions, special storage conditions, minimum language Every seller, in every province
Federal Medical Devices Regulations, section 44(1) An establishment licence to import or sell, with exemptions in 44(2) for retailers and health care facilities The importer and the seller
Ontario O. Reg. 246/22, sections 48 and 56 Supplies readily available; annual evaluation of the product range feeding purchasing decisions Licensees of long-term care homes
Ontario Occupational Health and Safety Act, section 25(2)(h) Every precaution reasonable for the protection of a worker Employers, including clinics
Quebec Charter of the French language, section 51 Every inscription on the product, its container, wrapping and accompanying documents in French Suppliers and sellers in Quebec
Quebec CLSC network Home support delivered through first-line services The health and social services network

What does the mL figure on the pack actually measure?

It measures the absorption capacity of the absorbent core under a defined laboratory procedure, and the method is ISO 11948-1:1996, whose scope is the absorption capacity of the core of body-worn urine-absorbing aids. The powder inside that core has its own tests — pH in ISO 17190-1:2020 — and none of them describes what happens at three in the morning.

Two consequences are worth carrying into a procurement file. Two products tested to the same method can still behave differently in use, because the method fixes the test and not the wearer. And a number with no method named behind it is not a specification, it is a claim.

What should a buyer ask before signing a case order?

  • Which edition of ISO 15621 the technical file was written against, and whether it is the 2026 edition.
  • Which test method produced the absorbency figure, and whether the report is available rather than the brochure line.
  • Which channel the pack was labelled for, and whether a French pack with French instructions exists for Quebec delivery.
  • Whether the inner pack count and the case count are stated the same way on the invoice and on the carton.
  • How the range will be evaluated with residents and direct care staff, since that evaluation is what Ontario's regulation ties to the purchasing decision.

References

  • Medical Devices Regulations, SOR/98-282, sections 21, 23, 26 and 44 — laws-lois.justice.gc.ca (checked 10 November 2026)
  • 21 CFR 876.5920, Protective garment for incontinence — law.cornell.edu (checked 10 November 2026)
  • 21 CFR 801.15, Prominence of required label statements — law.cornell.edu (checked 10 November 2026)
  • ISO 15621:2026, Absorbent incontinence products for urine, faeces, or both — published 19 February 2026 — genorma.com (checked 10 November 2026)
  • ISO 11948-1:1996, absorption capacity of the absorbent core — genorma.com (checked 10 November 2026)
  • ISO 11948-2:1998, withdrawn — genorma.com (checked 10 November 2026)
  • ISO 9949-1:1993, withdrawn 2 June 2021 — genorma.com (checked 10 November 2026)
  • ISO 17190-1:2020, polyacrylate superabsorbent powders, pH — genorma.com (checked 10 November 2026)
  • ISO 10993-1:2025, biological evaluation — genorma.com (checked 10 November 2026)
  • ISO 15223-1:2021, symbols for information supplied by the manufacturer — genorma.com (checked 10 November 2026)
  • O. Reg. 246/22, General, under the Fixing Long-Term Care Act, 2021, sections 48 and 56 — ontario.ca (checked 10 November 2026)
  • Occupational Health and Safety Act, R.S.O. 1990, c. O.1, section 25(2)(h) — ontario.ca (checked 10 November 2026)
  • Public Health Ontario, Routine Practices and Additional Precautions — publichealthontario.ca (checked 10 November 2026)
  • Charter of the French language, C-11, sections 51 and 51.1 — legisquebec.gouv.qc.ca (checked 10 November 2026)
  • Centre local de services communautaires (CLSC) — quebec.ca (checked 10 November 2026)

Related reading

Frequently asked questions

Which standard applies to adult pull-on diapers today?

ISO 15621:2026, published 19 February 2026, is the current evaluation guideline; it replaced the 2017 edition on the same date. The absorbency figure behind a millilitre rating is still produced by the test method in ISO 11948-1:1996.

Is 5,000 mL the amount one resident can void?

No. It is the absorption capacity of the absorbent core measured in a laboratory under ISO 11948-1, not a working volume. A care plan sets the change interval, and the number on the pack does not override it.

Does a pull-on diaper need a device licence in Canada?

Section 26 of the Medical Devices Regulations applies a device licence to Class II, III and IV devices, and a non-invasive absorbent product falls in Class I under the classification rules. What section 44(1) requires instead is an establishment licence to import or sell, with exemptions in 44(2) for retailers and health care facilities.

Are the mL ratings on different brands comparable?

Only if both brands name the same method and the same test conditions. Two products can pass the identical method and still behave differently on a resident, so the report matters more than the number.

Does Ontario's continence care regulation apply to a walk-in clinic?

No. O. Reg. 246/22 binds licensees of long-term care homes. A community clinic is bound by the federal labelling and establishment rules and, for worker protection, by the Occupational Health and Safety Act.

Do pull-on diapers have to be labelled in French?

On a Quebec sale, yes. Section 51 of the Charter of the French language requires every inscription on the product, its container or wrapping and the documents supplied with it, including the directions for use, to be in French. Under the federal regulation the minimum is English or French, with both required for devices sold to the general public.

Putting the standard stack to work

The clinic supply and cost planner turns a changes-per-day figure into a case schedule, and the compliance log centre carries the free printable logs that clinics keep beside the supply record. For an account covering several sites, the route is the institutional account enquiry page; where a clinic's incontinence waste ends up in the same written procedure as its reprocessing records, the sterilization compliance consultation page covers that side. Reselling? become a distributor.

CliniEco Medical distributes clinic consumables in Canada under MDEL #35334. This article describes requirements published by Health Canada, the Government of Ontario, the Government of Quebec and the United States federal register; the requirement that binds a specific clinic or home remains the one in its provincial guidance, its accreditation conditions and its own written procedure.

Last updated: 10 November 2026.

Already working with clinics? Become a regional representative.